Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001470831-26-000701 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 10, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
66,250
Total Value
$904,188.24
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 8, 2026 | Exercise/Conversion | 18,750 | $3.79 | $71,058.75 | 210,391 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 8, 2026 | Sale | 22,833 | $28.76 | $656,651.96 | 187,558 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 8, 2026 | Sale | 4,306 | $29.80 | $128,302.01 | 183,252 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 8, 2026 | Sale | 1,075 | $30.35 | $32,631.52 | 182,177 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 9, 2026 | Sale | 536 | $29.00 | $15,544.00 | 181,641 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jul 8, 2026 | Exercise/Conversion | 18,750 | $0.00 | $0.00 | 70,502 | Direct | โ | View Details |